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Case Report
Systemic Lupus Erythematosus presenting as Hemolytic Uremic Syndrome: a case report 
Malik Anas Rabbani, Bushra Ahmad, Sabeen Fatima Mekan, Suhail Muzaffar, Syed Sohail Ali
Department of Medicine, Aga Khan University Hospital, Karachi.
Abstract
Associating systemic lupus erythematosus (SLE),
with an initial presentation of hemolytic uremic syndrome
(HUS) is rare. We report a case of 21-year old Afghani
female admitted to our hospital with an initial complaint of
high grade fever and diffuse maculopapular rash and
swelling of lower limbs. Diagnosis of atypical HUS was
established according to the clinical triad of HUS without a
veriotoxin-producing organism in her stool and the patholog-
ical finding compatible to thrombotic microangiopathy. In addi-
tion, her symptoms fulfilled the 1982 revised criteria for the
classification of SLE. After pulse methylprednisolone,
cyclophosphamide and plasmapheresis therapies, her labora-
tory findings and general condition improved.
Unfortunately she was lost to follow up as she decided to
return back to Afghanistan.
Introduction
Hemolytic uremic syndrome (HUS) is characterized
by the triad of acute renal insufficiency, microangiopathic
hemolytic anemia (MAHA) and thrombocytopenia. It is a
rare cause of acute renal failure in adults. Systemic lupus
erythematosus (SLE) is an autoimmune disease character-
ized by production of autoantibodies and can cause alter-
ations in components of the connective tissue of multiple
organs. An association of HUS with SLE is rare. 
In this report, we describe a 21-year-old female with
SLE with an initial presentation of high grade fever, joint
pains, photosensitivity, generalized muco-papular rash,
nephrotic syndrome and non-diarrhea-associated HUS. The
patient had the classic HUS triad and a compatible patho-
logic findings. She had no diarrhea and did not have a veri-
otoxin-producing organism in her stool.
Case Report
A previously healthy 21-years-old female from
Afghanistan was admitted to the Aga Khan University
Hospital with high grade fever, joint pains, swelling of legs
and generalized maculo-papular rash for one week. In the
past she had complaints of mouth ulcers and photosensitiv-
ity. There was no history of vomiting or diarrhea. She also
complained of decreased urine output and coca cola-colored
urine.
On examination she had diffuse maculo-papular
rash. Her body temperature was 39.5°C, her blood pressure
was 160/100 mmHg, she had a regular heart rate of 110
beats/min, respiratory rate was 22/min and body weight was
55 kg. The conjunctiva was pale. She had bilateral pedal
edema. Systemic examination revealed bilateral pleural
effusion. Anterior abdominal wall was edematous without
rebound tenderness, muscle guarding or  visceromegally. At
admission she had oliguria (60 ml/24 hours).
Laboratory results revealed, hemoglobin 8.0 gm/dl
(normal 11.1-14.5 gm/dl), MCV of 86.2 fL (normal 76-96
fL), WBC 4.5 109/L (normal 4.0-10 109/L), a platelet count
of 84x109/L (normal 150-400x109/L),corrected reticulocyte
of number fraction 0.012 (normal number fraction 0.005-
0.015), serum LDH 1500 (normal 90-280 IU/L ), a negative
direct Coombs' test, blood urea nitrogen  48 mg/dl (normal
4-15), creatinine at 4.6 mg/dl (normal 0.6-1.3 mg/dl) and a
normal coagulation profile. Urine microscopy revealed
more than 20 RBC/HPF. Proteinuria was 3.5g/day.
Peripheral blood smear revealed schistocytosis, fragmented
RBCs, and helmet RBC (Figure 1). Her blood, urine, and
stool cultures were all negative. Veriotoxin-producing
organisms in the stool was negative. The initial clinical
diagnosis of hemolytic uremic syndrome (HUS) was made
based on the triad of hemolytic anemia, thrombocytopenia,
and acute renal failure. 
Other immunology studies showed antinuclear anti-
bodies +++ speckled, raised anti-dsDNA antibodies 32 IU
(normal 0-6) and low C3 complement fraction of 0.325 GL
(normal 0.738-1.80). Lupus anticoagulant and anticardi-
olipin antibodies IgG and IgM were negative. The diagno-
sis of SLE was therefore established. An ultra sound guided
biopsy of the left kidney was performed. Histological exam-
ination showed that it contained 12 glomeruli. By light
microscopy, all glomeruli displayed diffuse proliferation.
Arterioles had fibrinoid necrosis (Figure 2)and thrombotic
luminal occlusion (Figure 3). The interstitium was moder-
ately inflamed with infiltration, including neutrophilic infil-
tration. Immunofluorescent microscopy showed all
glomeruli stained with 3+IgG, 1+IgA, 2+IgM, 3+C3 and
fibrinogen in diffuse pattern. She received methylpred-
nisolone pulse therapy 1 g/day for 3 consecutive days. On
2nd day of pulse therapy she had an episode of brisk hemol-
ysis and her hemoglobin dropped to 5 gm/dl and serum cre-
atinine increased to 12 mg/dl. She subsequently received
plasma pheresis therapy (total of 5 cycles) along with
haemodialysis on alternate days. Oral cyclophosphamide
(1.25 mg/kg of body weight) was started on day 4 along
with oral steroids (1 mg/kg of body weight). Her renal func-
Figure 2. Light microscopy, all glomeruli displaying diffuse proliferation. Arterioles also had  fib-
rinoid necrosis
Figure 3. Light microscopic appearance of renal tissue showing thrombotic luminal occlusion.
Figure 1. Peripheral blood smear revealed schistocytosis, fragmented RBCs and          Helmet RBC.
Her renal function and hematological parameters
improved gradually as she became hemodialysis free and
her hemoglobin remained stable. She was discharged 1
month later with a hemoglobin level of 12 gm/dl, a platelet
count of 230 109/L, and serum creatinine at 3.2 mg/dl. She
was readmitted after one week with cellulitis of right leg
and was discharged after treatment with antibiotics.
Unfortunately she was lost to follow-up as she decided to
return to Afghanistan.
Discussion
HUS is characterized by the triad of acute renal
insufficiency, MAHA and thrombocytopenia. In HUS,
lesions are confined mainly to the kidney and thus renal fail-
ure is the dominant feature. In addition the makeup of the
clot is of a mixed thrombus, which occludes arterioles and
capillaries in microcirculation. HUS and thrombotic throm-
bocytopenic purpura (TTP)  are mainly distinguished from
each other by the location of the lesion and the defect of von
Willebrand factor, or a deficiency of the von Willebrand
factor-cleaving protease.1 Unlike TTP patients with HUS
show normal von Willebrand factors and cleaving protease
activity. Clinically, ours was a case of HUS with prominent
renal involvement but without any neurological symptoms,
though the von Willebrand factor and cleaving protease
were not checked.
Kwaan introduced the term thrombotic microangio-
pathic hemolytic anemia (TMHA) to comprise classic TTP
and HUS, as well as their association with pregnancy, neo-
plasm, certain drugs, and connective tissue disorders such
as systemic lupus erythematosus. Others have used
TTP/HUS to describe the combined condition.2
In SLE, microangiopathic anemia, usually associated
with diffuse vasculitis or malignant hypertension, may rarely
be detected. According to Nesher et al. and other reports, the
estimated incidence of thrombotic microangiopathy compli-
cating SLE occurs in at least 2% to 3% of patients, present-
ing this manifestation during the course of SLE.3 
Nesher et al. described the association of TTP/HUS
with SLE, however, their cases lacked patients with definite
HUS and SLE, as reviewed by Ogawa et al.2-4 Ogawa et al.
described a girl with SLE who also presented symptoms of
HUS. The additional diagnosis of HUS was established by
a peripheral blood smear finding and not by pathological
findings.4 Our patient presented with the diagnostic triad of
acute renal insufficiency, MAHA (Coombs'-negative reac-
tion) with fragmented erythrocytes, and thrombocytopenia.
Her renal biopsy revealed the characteristic pathologic
lesions of thrombotic angiopathy in HUS, in addition to the
finding of lupus nephritis of diffuse proliferative glomeru-
lonephritis. There were never any neurological symptoms.
Though she did not have tests for von Willebrand factor or
the von Willebrand factor-cleaving protease evaluation,
HUS was diagnosed by both clinical and pathological
means. She also met the 1982 revised criteria for the classi-
fication of SLE.5 She presented with symptoms of HUS
simultaneously with SLE and was thus diagnosed as having
both.
Though SLE is a sporadic, noninfectious cause of
HUS, it is not known whether a pathogenic relationship
exists between these two diseases. Several hypotheses have
been proposed to explain the mechanism of the association
between TTP/HUS and SLE, including the presence of cir-
culation antiplatelet antibodies, antiendothelial antibodies,
or immune complexes.6,7 The role of antiphospholipid anti-
bodies is also speculative.8 Anticardiolipin antibodies was
negative in our patient. However, the precise mechanisms
for these correlations are still to be defined.
It may be difficult to differentiate clinically between
antiphospholipid syndrome and TMHA. Careful laboratory
testing should greatly help in the differentiation. To diag-
nose HUS, a peripheral blood smear should reveal the pres-
ence of schistocytes (fragmented erythrocytes). In addition,
Coombs' test results are usually negative.3
Prognosis of HUS in adults is poor. Tonshoff et al.
demonstrated that 33% of HUS patients developed
CRF/ESRD, or they died.9 Fitzpatrick et al. suggested that
plasmaphresis might improve the poor prognosis of atypical
HUS in adults.9 From reviews of the published cases of
TTP/HUS in SLE by Nesher et al, plasmapheresis and/or
plasma infusion appear to be beneficial adjuncts to therapy
with steroids.3 
Our patient's condition also improved after we initi-
ated plasmapheresis treatment. We believe that the clinical
improvement of our case with plasmapheresis appears to
support the opinion of Fitzpatrick et al.9 
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